New approach combines two methods to study disordered proteins

Researchers of Mainz University and EMBL Hamburg present a new approach to determine the form of disordered proteins by using two different methods simultaneously in a single sample.

FDA approves Ipsen’s Onivyde as first-line treatment for type of pancreatic cancer

The FDA on Tuesday approved Ipsen’s cancer drug Onivyde as the first-line treatment for a type of pancreatic cancer, to be used alongside other cancer

February 14, 2024

Do taste genes influence how much alcohol we drink and our body fat?

Study examines how polymorphisms in bitter taste receptor genes relate to alcohol consumption and body fat percentage, revealing significant associations with TAS2R13 but not TAS2R38.

June 10, 2024

FDA Outlines Rules for Telling Clinicians About Unapproved Uses of Drugs, Devices

The FDA has released revised draft guidance on communicating with healthcare professionals (HCPs) about unapproved uses of approved drugs and devices. Once it’s finalized, the

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.